EPS (Diluted) for Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current diluted EPS (TTM) is $8.50. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$8.50
YoY change
+90.5%
5Y CAGR
+14.9%
Peak year (2023)
$13.72
Latest annual
$11.03
EPS (Diluted) history chart for Johnson & Johnson (JNJ) from 1985 to 2025
EPS (Diluted) history table for Johnson & Johnson (JNJ) from 1985 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $11.03 | +90.5% | ||
| 2024 | $5.79 | -57.8% | ||
| 2023 | $13.72 | +103.9% | ||
| 2022 | $6.73 | -13.8% | ||
| 2021 | $7.81 | +41.7% | ||
| 2020 | $5.51 | -2.1% | ||
| 2019 | $5.63 | +0.4% | ||
| 2018 | $5.61 | +1093.6% | ||
| 2017 | $0.47 | -92.1% | ||
| 2016 | $5.93 | +8.2% | ||
| 2015 | $5.48 | -3.9% | ||
| 2014 | $5.70 | +18.5% | ||
| 2013 | $4.81 | +24.6% | ||
| 2012 | $3.86 | +10.6% | ||
| 2011 | $3.49 | -27.0% | ||
| 2010 | $4.78 | +8.6% | ||
| 2009 | $4.40 | -3.7% | ||
| 2008 | $4.57 | +25.9% | ||
| 2007 | $3.63 | -2.7% | ||
| 2006 | $3.73 | +11.3% | ||
| 2005 | $3.35 | +22.3% | ||
| 2004 | $2.74 | +19.7% | ||
| 2003 | $2.29 | +6.0% | ||
| 2002 | $2.16 | +17.4% | ||
| 2001 | $1.84 | +14.3% | ||
| 2000 | $1.61 | +15.8% | ||
| 1999 | $1.39 | +31.1% | ||
| 1998 | $1.06 | -12.4% | ||
| 1997 | $1.21 | +11.0% | ||
| 1996 | $1.09 | +17.2% | ||
| 1995 | $0.93 | +19.2% | ||
| 1994 | $0.78 | +14.7% | ||
| 1993 | $0.68 | +325.0% | ||
| 1992 | $0.16 | -70.4% | ||
| 1991 | $0.54 | +25.6% | ||
| 1990 | $0.43 | +7.5% | ||
| 1989 | $0.40 | +14.3% | ||
| 1988 | $0.35 | +12.9% | ||
| 1987 | $0.31 | +158.3% | ||
| 1986 | $0.12 | -42.9% | ||
| 1985 | $0.21 | — |
EPS (Diluted) values are taken from Johnson & Johnson's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Johnson & Johnson (JNJ) diluted EPS is $11.03 – surged 90.5% year-over-year.
Over 2020–2025 (5 years), Johnson & Johnson diluted EPS expanded at a +14.9% compound annual rate, with the latest reading among the more recent periods of the dataset.
Johnson & Johnson diluted EPS declined from $13.72 in 2023 to $11.03 in 2025, a 19.6% drawdown.
2023 marks the peak diluted EPS at $13.72, with the historical low of $0.12 recorded in 1986.
Johnson & Johnson (JNJ) sits 7th of 8 Healthcare peers we track on this metric, against a peer median of $13.73.
Johnson & Johnson EPS (Diluted) by Year
Johnson & Johnson EPS (Diluted) 2025: $11.03
Johnson & Johnson diluted EPS in 2025 was $11.03, surged 90.5% from 2024.
Johnson & Johnson EPS (Diluted) 2024: $5.79
Johnson & Johnson diluted EPS in 2024 was $5.79, plunged 57.8% below 2023.
Johnson & Johnson EPS (Diluted) 2023: $13.72
Johnson & Johnson diluted EPS in 2023 was $13.72, surged 103.9% from 2022. This figure represents the highest annual value in the available history.
Johnson & Johnson EPS (Diluted) 2022: $6.73
Johnson & Johnson diluted EPS in 2022 was $6.73, declined 13.8% below 2021.
Johnson & Johnson EPS (Diluted) 2021: $7.81
Johnson & Johnson diluted EPS in 2021 was $7.81.
See more financial history for Johnson & Johnson (JNJ).
Sector peers — EPS (Diluted)
Companies in the same sector as Johnson & Johnson, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $17.74 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Johnson & Johnson's diluted EPS?
- Latest reported diluted EPS for Johnson & Johnson (JNJ) is $8.50 (period ending March 31, 2026).
How has Johnson & Johnson diluted EPS changed year-over-year?
- Johnson & Johnson (JNJ) diluted EPS changed +90.5% year-over-year on the latest annual filing.
What is the long-term growth rate of Johnson & Johnson diluted EPS?
- Johnson & Johnson (JNJ) diluted EPS compound annual growth rate is +14.9% over the most recent 5 years available.
When did Johnson & Johnson diluted EPS hit its highest annual value?
- Johnson & Johnson diluted EPS reached its highest annual value of $13.72 in 2023.
What was Johnson & Johnson diluted EPS in 2024?
- Johnson & Johnson (JNJ) diluted EPS in 2024 was $5.79.
What was Johnson & Johnson diluted EPS in 2025?
- Johnson & Johnson (JNJ) diluted EPS in 2025 was $11.03.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
JNJ Overview
Company profile, financial tools, and key metrics
JNJ Revenue Counter
Earns $3,066 every second. See per minute, hour, and day.
JNJ Earnings Counter
Earns $657.60 per second net profit. See per minute, hour, and day.
JNJ Economic Scale
Exceeds Costa Rica's GDP. Compare with world economies.
JNJ What If Invested
What if you had invested $1,000? See historical returns from any date.
JNJ How It Makes Money
Discover visual breakdown of $96.68B in revenue — where it comes from and where it goes.
JNJ Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
JNJ Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
JNJ Daily Price Character
Steady · 47.0% historical win rate (green days). Streaks & record days.
JNJ Buybacks
1.00% TTM buyback yield. Shareholder yield & SBC comparison.
JNJ Stock Split History
7 splits on record. Dates, ratios, and cumulative multiple.
JNJ Dividend Profile
Yield: 2.29%. Safety: 6/8. See full history.
JNJ Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
JNJ Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.